CAROLYN AHN: Open Payments
NPI 1033754098 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,038 in 54 payments from 23 companies in 2025. Trend: 2023 $1,069 · 2024 $1,364 · 2025 $1,038
Food & beverage: $1,038
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 8 | $167 |
| Novo Nordisk Inc | 11 | $165 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $94 |
| ABBVIE INC. | 3 | $73 |
| Seqirus USA Inc | 3 | $66 |
| Axsome Therapeutics, Inc. | 3 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $48 |
| Avvisto Therapeutics, LLC | 2 | $38 |
| DePuy Synthes Sales Inc. | 1 | $38 |
| Abbott Laboratories | 2 | $37 |
Products named: Wegovy, TRELEGY ELLIPTA, QULIPTA, Kerendia, Flucelvax, CYCLOSET, MOTOBAND, JARDIANCE.
Industry payments across TX — which companies pay providers there.
